Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathwaysQi Feng(Second Military Medical University), Yuan‐Sheng Zang(Shanghai Changzheng Hospital)Oncology LettersJanuary 3, 201910.3892/ol.2019.9884Cited by 31SaveCiteExport RISWatch citationsRelated PapersLow-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells|Cellular Oncology|2022|18